177 related articles for article (PubMed ID: 3945672)
1. Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+).
Morikawa F; Ueda T; Arai Y; Kinemuchi H
Pharmacology; 1986; 32(1):38-45. PubMed ID: 3945672
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
Fowler CJ; Eriksson M; Thorell G; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
[TBL] [Abstract][Full Text] [Related]
3. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
Kinemuchi H; Morikawa F; Ueda T; Arai Y
Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.
Eriksson M; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):273-8. PubMed ID: 6514011
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
Ask AL
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
[TBL] [Abstract][Full Text] [Related]
7. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II. Inhibition by alpha-methylated substrate-analogue monoamines, alpha-methyltryptamine, alpha-methylbenzylamine and two enantiomers of alpha-methylbenzylamine.
Arai Y; Toyoshima Y; Kinemuchi H
Jpn J Pharmacol; 1986 Jun; 41(2):191-7. PubMed ID: 3747266
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase-A selective inhibition in human hypothalamus and liver in-vitro by amiflamine and its metabolites.
Tipton KF; O'Carroll AM; McCrodden JM; Fowler CJ
J Pharm Pharmacol; 1985 May; 37(5):352-4. PubMed ID: 2862247
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
Ask AL; Fagervall I; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
[TBL] [Abstract][Full Text] [Related]
10. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.
Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L
Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012
[TBL] [Abstract][Full Text] [Related]
12. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
Andree TH; Clarke DE
Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
[TBL] [Abstract][Full Text] [Related]
14. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
Ask AL; Fagervall I; Huang RB; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil.
Arai Y; Nakazato K; Kinemuchi H; Tadano T; Satoh N; Oyama K; Kisara K
Neuropharmacology; 1991 Jul; 30(7):809-12. PubMed ID: 1922690
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
[TBL] [Abstract][Full Text] [Related]
17. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.
Rényi L; Ross SB
Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634
[TBL] [Abstract][Full Text] [Related]
18. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Ramos K; Grossman SL; Cox LR
Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp.
Vavilova T; Ostrovskaya I; Axenova L; Buneeva O; Medvedev A
Med Sci Monit; 2009 Oct; 15(10):BR289-292. PubMed ID: 19789505
[TBL] [Abstract][Full Text] [Related]
20. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
